SCHEMBL26654402

SCHEMBL26654402

COc1cc2c(cc1Br)SC(C=O)N2C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 2/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ GRIN2D O15399 1/20 0.34
▸ GRIN3B O60391 1/20 0.34
▸ GRIN1 Q05586 1/20 0.34
▸ GRIN2A Q12879 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34
▸ GRIN2C Q14957 1/20 0.34
▸ GRIN3A Q8TCU5 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HTR2A P28223 4/20 0.32
▸ ERN1 O75460 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26654624 0.82 HTR2A (0.34) PTPN1PRKDCGRIN2DGRIN3BGRIN1
SCHEMBL27856092 0.72 MYC (0.34) MEN1KMT2AL3MBTL1HTR2AERN1
SCHEMBL27746292 0.67 GAA (0.33) MEN1KMT2AALDH1A1
SCHEMBL28094908 0.66 GRIA1 (0.39) KMT2ALMNAALDH1A1POLBSMN1; SMN2
SCHEMBL30659677 0.66 HTR2A (0.37) PTPN1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1104878 0.64 GRIN2D (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27516784 0.64 MAOA (0.41) ALDH1A1SMN1; SMN2
SCHEMBL9507682 0.64 GRIN2D (0.44) PTPN1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL698744 0.63 PRKDC (0.81) PRKDCGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL28120791 0.63 MYC (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023216753-A1 IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE 上海赛默罗生物科技有限公司 2023-11-16 — — WO disclosed
Send feedback